Heart outcomes

We have assembled a nationally respected team of doctors and clinicians at Tyler Heart Institute. You can receive the most advanced care, right here in the comfort of your own community. After your procedure, we will provide you with the rehabilitation and lifestyle coaching you will need. Included below are quality measures for three different types of heart procedures. We consistently strive for the best quality and recovery for our patients.

Our cardiac program

Cardiac Surgery Outcomes

January-December 2018
CHOMP US*
Lower is better

Major cardiac surgery procedures combined in-hospital mortality rate
(CABG, Valve, and Valve+CABG Procedures Combined)

Better 1.6% 2.0%
Any Major Complications or Mortality for Coronary Artery Bypass (CABG) Procedures ** Below 14.7% 12.0%
Post-Procedure Length of Stay for Coronary Artery Bypass (CABG)
Average post-procedure length of stay in days for Coronary Artery Bypass (CABG)
Better 6.0 7.0
Readmission rates for Coronary Artery Bypass (CABG) procedures
Percent of patients readmitted to the hospital within 30 days after discharge
Better 5.5% 10.1%
*National benchmarks are provided by the Society of Thoracic Surgeons (STS)
**This is a measure of combined outcomes. It is true if any of the following are indicated: Operative mortality, reoperation for any cause, permanent stroke, prolonged ventilation, deep sternal wound infection, or renal failure.

Transcatheter Aortic Valve Replacement (TAVR) Outcomes*

January-December 2018
CHOMP US**
Lower is better
In-hospital mortality rate
Observed rate; all-cause mortality rate; not risk-adjusted
Better 0% 1.5%
Any Complications*** Below 26.1% 20.6%
Post-procedure length of stay in days
Average post-procedure length of stay in days for patients with TAVR
Better 2.5 2.9
*Transcatheter aortic valve replacement (TAVR) is a minimally invasive surgical procedure that repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place (Source: American Heart Association).
**National benchmark as the aggregated value for the measure/metric across all US patients is provided by the Society of Thoracic Surgeons and American College of Cardiology (STS/ACC) TVT Registry
***This is a measure of combined outcomes. It is true if any of the following are indicated: Cardiac complications, neurologic complications, renal complications, bleeding, and vascular complications, or device complications.

Interventional Cardiology: PCI Outcomes*

January-December 2018
CHOMP US**
Lower is better
Observed in-hospital mortality rate
The observed in-hospital mortality rate for all patients having PCI; not risk-adjusted
Better 1.4% 1.9%

Guideline Medications Prescribed at Discharge
Percentage of PCI patients who were prescribed all medications (aspirin, statin and/or P2Y12 Inhibitor) for which they were eligible

Below 87.7% 96.4%

Median Door to Balloon Time in STEMI
Median time (in minutes) from arrival to first device activation time of PCI procedures for STEMI procedures

Below 65min 60min

Major adverse events (all PCI patients)

Below 3.4% 2.6%
Post-procedure length of stay in days
Median time (in days) from the start of the PCI procedure to discharge for all STEMI patients
Below 2.0 1.9
* Percutaneous coronary intervention (PCI) is a non-surgical procedure used to treat narrowing (stenosis) of the coronary arteries of the heart found in coronary artery disease.
**National benchmark as the aggregated value for the measure/metric across all US patients is provided by the American College of Cardiology Foundation CathPCI Registry